Category Archives: Healthcare

Analysts Offer Insights on Healthcare Companies: Allergan (NYSE: AGN) and Abbott Labs (NYSE: ABT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Allergan (NYSE: AGN) and Abbott Labs (NYSE: ABT) with bullish sentiments. Allergan (NYSE: AGN) RBC Capital analyst Randall Stanicky reiterated a Buy

Supernus Pharmaceuticals Initiated with a Buy at FBR Capital

In a report released yesterday, David Buck from FBR Capital initiated coverage with a Buy rating on Supernus Pharmaceuticals (NASDAQ: SUPN) and a price target of $53. The company’s shares closed yesterday at $41.25. Buck noted: “We are initiating coverage

Repligen Corp Receives a Rating Update from a Top Analyst

In a report released yesterday, Brandon Couillard from Jefferies reiterated a Hold rating on Repligen Corp (NASDAQ: RGEN), with a price target of $40. The company’s shares closed yesterday at $36.27. According to TipRanks.com, Couillard is a top 100 analyst

Enzymotec Gets a Hold Rating from Jefferies

Jefferies analyst Laurence Alexander reiterated a Hold rating on Enzymotec (NASDAQ: ENZY) on October 17 and set a price target of $11.50. The company’s shares closed yesterday at $11.15. According to TipRanks.com, Alexander is a top 25 analyst with an

Analysts Offer Insights on Healthcare Companies: Abbott Labs (NYSE: ABT), China Biologic (NASDAQ: CBPO) and Insys Therapeutics (NASDAQ: INSY)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Labs (NYSE: ABT), China Biologic (NASDAQ: CBPO) and Insys Therapeutics (NASDAQ: INSY) with bullish sentiments. Abbott Labs (NYSE: ABT) Jefferies analyst

The Executive VP of Daxor Corp (NYSE MKT: DXR) is Buying Shares

Yesterday, the Executive VP of Daxor Corp (NYSE MKT: DXR), Michael Richard Feldschuh, bought shares of DXR for $999. The company has a one-year high of $9.80 and a one-year low of $4.66. Currently, Daxor Corp has an average volume